Fact CheckerSign in

NCT07541859Not yet recruiting

Breast and Cervical Cancer Awareness Training in Visually Impaired Women

The Effect of Awareness Education on Breast and Cervical Cancer Screening Among Visually Impaired Women

Source: ClinicalTrials.gov · Last updated 21 Apr 2026

Brief summary (registry, in English)

This quasi-experimental study aims to determine whether a breast and cervical cancer awareness training program can increase participation in cancer screening among women with visual impairments. The study also aims to identify barriers to screening and improve knowledge about cancer risk factors and screening methods. The main questions this study will address are: * Does the training increase the rate at which women with visual impairments attend cancer screening appointments? * Does the training improve participants' knowledge about breast and cervical cancer? Participants will: * Receive training on breast and cervical cancer risk factors and screening methods. * Learn how to apply to the Cancer Early Diagnosis, Screening, and Training Center. * Be encouraged to attend cancer screening during the study period. * Have knowledge and screening status assessed before the training, immediately after, and three months later.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
74 (estimated)
First submitted
20 Aug 2025
Start date
Jun 2026
Primary completion date
Jul 2026
Lead sponsor
Marmara University
NCT number
NCT07541859

What you commit to

  • Study type: Interventional
  • Planned participants: 74
  • From Jun 2026 to the primary completion date, Jul 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have undergone screening for at least one of these two cancer types (breast or cervical) within the last year
    • According to the Turkish Ministry of Health, General Directorate of Public Health, in current screenings conducted in our country, within the breast cancer screening program for women, mammography is recommended every two years for women aged 40-69, and within the cervical cancer screening program, Pap smear and HPV-DNA tests are recommended every five years for women aged 30-65. Since women will be referred by the researchers to KETEM centers after training to undergo mammography and Pap smear screening tests, visually impaired women over the age of 40 who have previously had sexual intercourse will be included in the study, as these two screening tests are performed in this common age group and Pap smear screening requires being sexually active.

Other illness

  • Diagnosed with breast or cervical cancer

Age

  • Under the age of 40

Other

  • Have not had sexual intercourse before

Who the study is looking for

  • Women with only a visual impairment (congenital or acquired)
  • Able to communicate, speak, and understand Turkish
  • Voluntarily agree to participate in the study
  • Over the age of 40
  • Have had previous sexual intercourse (Pap smear screening requires sexual activity)

Criteria the registry did not label

  • Eligibility Criteria

Age in the registry: 40 years to - · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Turkish Association for the Blind
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status
Altınokta Association of the Blind
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.